Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans

Nutrition and Metabolism

Volumn 9, Issue , 2012, Pages

  Cox, Chad L ^a   Stanhope, Kimber L ^a   Schwarz, Jean Marc ^b   Graham, James L ^a   Hatcher, Bonnie ^a   Griffen, Steven C ^c   Bremer, Andrew A ^d   Berglund, Lars ^c   McGahan, John P ^f   Keim, Nancy L ^a,e   Havel, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Touro University California   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e U S DEPARTMENT OF AGRICULTURE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FRUCTOSE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; RETINOL BINDING PROTEIN 4; URIC ACID;

ADULT; AGED; ARTICLE; BEVERAGE; BLOOD ANALYSIS; DIET RESTRICTION; ENERGY; ENZYME ACTIVITY; FEMALE; GLUCOSE INTAKE; HUMAN; MALE; OBESITY; PARALLEL DESIGN; POSTPRANDIAL STATE; PROTEIN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 84867076729     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-9-68     Document Type: Article

References (46)

1. Dietary assessment of major trends in U.S. food consumption, 1970-2005. Wells FW, Buzby JC, Economic Information Bulletin No. 33. Economic Research Service, U.S. Dept. of Agriculture 2008 1 20
2. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Bray GA, Nielsen SJ, Popkin BM, Am J Clin Nutr 2004 79 537 543 15051594
3. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Havel PJ, Nutr Rev 2005 63 133 157 10.1111/j.1753-4887.2005.tb00132.x 15971409
4. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K, Am J Physiol Endocrinol Metab 2010 299 685 E694 10.1152/ajpendo.00283.2010 20823452
5. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH, Nat Rev Gastroenterol Hepatol 2010 7 251 264 10.1038/nrgastro.2010.41 20368739
6. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ, J Clin Invest 2009 119 1322 1334 10.1172/JCI37385 19381015
7. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Stanhope KL, Havel PJ, Curr Opin Lipidol 2008 19 16 24 10.1097/MOL.0b013e3282f2b24a 18196982
8. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Yamada J, Tomiyama H, Yambe M, Koji Y, Motobe K, Shiina K, Yamamoto Y, Yamashina A, Atherosclerosis 2006 189 198 205 10.1016/j.atherosclerosis.2005.11.036 16405892
9. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. Yu MA, Sanchez-Lozada LG, Johnson RJ, Kang DH, J Hypertens 2010 28 1234 1242 20486275
10. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sanchez-Lozada LG, Am J Clin Nutr 2007 86 899 906 17921363
11. Systemic inflammation, metabolic syndrome and progressive renal disease. Cirillo P, Sautin YY, Kanellis J, Kang DH, Gesualdo L, Nakagawa T, Johnson RJ, Nephrol Dial Transplant 2009 24 1384 1387 10.1093/ndt/gfp038 19208772
12. Association between serum uric acid level and chronic liver disease in the United States. Afzali A, Weiss NS, Boyko EJ, Ioannou GN, Hepatology 2010 52 578 589 10.1002/hep.23717 20683957
13. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Simao AN, Dichi JB, Barbosa DS, Cecchini R, Dichi I, Nutrition 2008 24 675 681 10.1016/j.nut.2008.03.021 18499396
14. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Goessling W, Massaro JM, Vasan RS, D'Agostino RB Sr, Ellison RC, Fox CS, Gastroenterology 2008 135 1935 1944 1944 e1931 10.1053/j.gastro.2008.09.018 19010326
15. Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients. Chang YH, Lin KD, Wang CL, Hsieh MC, Hsiao PJ, Shin SJ, Diabetes Metab Res Rev 2008 24 629 634 10.1002/dmrr.894 18973209
16. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Kloting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Fasshauer M, Schon MR, Stumvoll M, Bluher M, Kahn BB, Cell Metab 2007 6 79 87 10.1016/j.cmet.2007.06.002 17618858
17. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB, Nature 2005 436 356 362 10.1038/nature03711 16034410
18. Levels of retinol-binding protein 4 and uric acid in patients with type 2 diabetes mellitus. Chen CC, Wu JY, Chang CT, Tsai FJ, Wang TY, Liu YM, Tsui HC, Chen RH, Chiou SC, Metabolism 2009 58 1812 1816 10.1016/j.metabol.2009.06.013 19709697
19. A new predictive equation for resting energy expenditure in healthy individuals. Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO, Am J Clin Nutr 1990 51 241 247 2305711
20. High-fat meals reduce 24-h circulating leptin concentrations in women. Havel PJ, Townsend R, Chaump L, Teff K, Diabetes 1999 48 334 341 10.2337/diabetes.48.2.334 10334310
21. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. Teff KL, Elliott SS, Tschop M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ, J Clin Endocrinol Metab 2004 89 2963 2972 10.1210/jc.2003-031855 15181085
22. Adipocytokine profile of type 2 diabetics in metabolic syndrome as defined by various criteria. Al-Daghri NM, Al-Attas OS, Al-Rubeaan K, Sallam R, Diabetes Metab Res Rev 2008 24 52 58 10.1002/dmrr.763 17657721
23. Follow-up report on the diagnosis of diabetes mellitus. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, Diabetes Care 2003 26 3160 3167 14578255
24. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Perez-Pozo SE, Schold J, Nakagawa T, Sanchez-Lozada LG, Johnson RJ, Lillo JL, Int J Obes (Lond) 2010 34 454 461 10.1038/ijo.2009.259
25. Blood lipids, lipoproteins, apoproteins, and uric acid in men fed diets containing fructose or high-amylose cornstarch. Reiser S, Powell AS, Scholfield DJ, Panda P, Ellwood KC, Canary JJ, Am J Clin Nutr 1989 49 832 839 2497634
26. Acute, food-induced moderate elevation of plasma uric acid protects against hyperoxia-induced oxidative stress and increase in arterial stiffness in healthy humans. Vukovic J, Modun D, Budimir D, Sutlovic D, Salamunic I, Zaja I, Boban M, Atherosclerosis 2009 207 255 260 10.1016/j.atherosclerosis.2009.04.012 19457484
27. Intermediary metabolism of fructose. Mayes PA, Am J Clin Nutr 1993 58 754S 765S 8213607
28. Effect of oral fructose on urate production. Emmerson BT, Ann Rheum Dis 1974 33 276 280 10.1136/ard.33.3.276 4843132
29. Uric acid and oxidative stress. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA, Curr Pharm Des 2005 11 4145 4151 10.2174/138161205774913255 16375736
30. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Bonora E, Capaldo B, Perin PC, Del Prato S, De Mattia G, Frittitta L, Frontoni S, Leonetti F, Luzi L, Marchesini G, Marini MA, Natali A, Paolisso G, Piatti PM, Pujia A, Solini A, Vettor R, Bonadonna RC, Nutr Metab Cardiovasc Dis 2008 18 624 631 10.1016/j.numecd.2007.05.002 18060751
31. Epidemiological association between uric acid concentration in plasma, lipoprotein(a), and the traditional lipid profile. Lippi G, Montagnana M, Luca Salvagno G, Targher G, Cesare Guidi G, Clin Cardiol 2010 33 76 E80 21184549
32. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes. Wolf G, Nutr Rev 2007 65 251 256 10.1111/j.1753-4887.2007.tb00302.x 17566551
33. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB, N Engl J Med 2006 354 2552 2563 10.1056/NEJMoa054862 16775236
34. Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Tschoner A, Sturm W, Engl J, Kaser S, Laimer M, Laimer E, Weiss H, Patsch JR, Ebenbichler CF, Obesity (Silver Spring) 2008 16 2439 2444 10.1038/oby.2008.391
35. The metabolic role of retinol binding protein 4: an update. Christou GA, Tselepis AD, Kiortsis DN, Horm Metab Res 2012 44 6 14 22205567
36. Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions. Stanhope KL, Griffen SC, Bremer AA, Vink RG, Schaefer EJ, Nakajima K, Schwarz JM, Beysen C, Berglund L, Keim NL, Havel PJ, Am J Clin Nutr 2011 94 112 119 10.3945/ajcn.110.002246 21613559
37. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Rutledge AC, Adeli K, Nutr Rev 2007 65 13 S23 10.1301/nr.2007.jun. S13-S23 17605309
38. Effects of a short-term overfeeding with fructose or glucose in healthy young males. Ngo Sock ET, Le KA, Ith M, Kreis R, Boesch C, Tappy L, Br J Nutr 2010 103 939 943 10.1017/S0007114509992819 19930762
39. Hepatic gamma-glutamyltransferase activity in alcoholic fatty liver: comparison with other liver enzymes in man and rats. Teschke R, Neuefeind M, Nishimura M, Strohmeyer G, Gut 1983 24 625 630 10.1136/gut.24.7.625 6134656
40. Gamma-glutamyl transpeptidase, triglycerides, and enzyme induction. Martin PJ, Martin JV, Goldberg DM, Br Med J 1975 1 17 18 10.1136/bmj.1.5948.17 235344
41. Relationship between gamma-glutamyltransferase, lipids and lipoprotein(a) in the general population. Lippi G, Targher G, Montagnana M, Salvagno GL, Guidi GC, Clin Chim Acta 2007 384 163 166 10.1016/j.cca.2007.06.005 17601521
42. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Thamer C, Tschritter O, Haap M, Shirkavand F, Machann J, Fritsche A, Schick F, Haring H, Stumvoll M, Horm Metab Res 2005 37 246 251 10.1055/s-2005-861411 15952086
43. Hepatic fat content-independent association of the serum level of gamma-glutamyltransferase with visceral adiposity, but not subcutaneous adiposity. Iwasaki T, Yoneda M, Kawasaki S, Fujita K, Nakajima A, Terauchi Y, Diabetes Res Clin Pract 2008 79 13 e14 17900742
44. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients. Verrijken A, Francque S, Mertens I, Talloen M, Peiffer F, Van Gaal L, Int J Obes (Lond) 2010 34 899 907 10.1038/ijo.2010.4
45. Serum gamma-glutamyltransferase: new insights about an old enzyme. Lee DH, Jacobs DR Jr, J Epidemiol Community Health 2009 63 884 886 10.1136/jech.2008.083592 19825792
46. Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease. Devers MC, Campbell S, Shaw J, Zimmet P, Simmons D, Diabet Med 2008 25 523 529 10.1111/j.1464-5491. 2008.02408.x 18346165